Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teva Accupril Generic Delayed Until 2007; Pfizer Patent Is Valid, Court Says

Jun 30 2004

• By Sue Sutter

Related Content

Pfizer’s Plans To Market Accupril As A “Branded Generic” Challenged By Teva

Jun 21 2004

Mylan Demands FDA Response On “Authorized” Generics By July 6

Jun 30 2004

P&amp;G/Watson Macrobid "Authorized" Generic Launch Prompts Mylan Lawsuit

Mar 24 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window